Just Released: "Bangladesh Pharmaceuticals & Healthcare Report Q1 2014"
While economic growth is boosting demand for pharmaceuticals in Bangladesh, income inequality continues to drive the purchase of counterfeit medicines. In November 2013, the government vowed to continue fighting the growing industry of substandard, counterfeit and life-endangering medicines - a positive development for patients. Counterfeiting hijacks brands and infringes legitimate pharmaceutical manufacturers' patent and trademark rights - affecting their revenue-earning abilities in the Bangladeshi pharmaceutical market.
View full press release